Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.
CAS Registry Number
15708-41-5
Molecular formula
C10H12FeN2NaO8
Molecular weight
367.05 g/mol
Drug class
Oral iron preparationsodium ferric EDTA chelate
Mechanism of action
Sodium feredetate is a ferric iron chelate with EDTA. Following gastrointestinal hydrolysis, iron is released and absorbed, becoming available for haemoglobin synthesis and restoration of iron stores.
Indications / reported uses
Prevention and treatment of iron-deficiency anaemia and iron deficiency with oral sodium feredetate products, according to the product label.
Scope is agreed for the exact substance form, intended use, exposure route, workplace context and available toxicological evidence.
PDE/ADE: critical effects, point of departure and justified adjustment factors.
OEL: inhalation hazards, exposure duration and workplace conditions.
OEB/OHC: evidence-based banding where requested; a band is not a numerical OEL.
Report: scientific rationale, source data, assumptions, uncertainties and limitations.
Assessment scope
PDE/ADE and OEL/OEB assessment
ReguSight provides project-specific support for Feredetate PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Feredetate Permitted Daily Exposure (PDE) report (the Feredetate PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Feredetate Occupational Exposure Limit (OEL) report (the Feredetate OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.
Assessment may cover
PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.